Rachel Brody - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Rachel Brody's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Rachel Brody

Rachel Brody

Verified

Senior Staff Editor, Flexible Editing Desk, The New York Times

New York

Biography

#N/A

Final Covers

Breaking News , National News , Opinion

Doesn’t Cover

I really don't care about Godzilla, sorry.

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 296

  • Business as usual

    By Rachel Brody Verified| The Times of Israel Verified May 21, 2021, 2:14 PM@ Please note that the posts on The Blogs are contributed by third parties. The opinions, facts and any media content in them are presented solely by the authors, and neither The Times of Israel nor its partners assume any responsibility for them. Please contact us in case of abuse. In case of abuse, Report this post.

    By Rachel Brody Verified · The Times of Israel

    May. 21, 2021

  • A Novel Artificial Intelligence-powered Tool for Precise Risk Stratification of Prostate Cancer Progression in Patients with Clinical Intermediate Risk - European Urology

    By Sujit Nair Verified, Hassan Muhammad, Rachel Brody Verified, Cell-Based Medicine| European Urology Verified Get full text accessLog in, subscribe or purchase for full access. ReferencesKane, C.J. ∙ Eggener, S.E. ∙ Shindel, A.W. ... Variability in outcomes for patients with intermediate-risk prostate cancer (Gleason score 7, International Society of Urological Pathology Gleason group 2–3) and implications for risk stratification: a systematic reviewEur Urol Focus. 2017; 3:487-497Kurbegovic, S. ∙ Drimer Berg, K. ∙ Birkebæk Thomsen, F. ...

    By Sujit Nair Verified, Hassan Muhammad, Rachel Brody Verified, Cell-Based Medicine · European Urology

    Sep. 03, 2024

  • Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer

    By Philip C. Mack, Juan Manuel Carreno, Rachel Brody Verified, Amy Moore| Cell Press Verified These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

    By Philip C. Mack, Juan Manuel Carreno, Rachel Brody Verified, Amy Moore · Cell Press

    Oct. 19, 2023

As seen in

Company Info

The New York Times

New York, New York, United States

'+1 800-698-4637